Key result
Aspirin and other cyclo-oxygenase inhibitors have diverse therapeutic applications, including potential benefits in transient ischaemic attacks, coronary artery disease, and dysmenorrhoea.
Aspirin and other cyclo-oxygenase inhibitors have broad therapeutic applications, including in coronary artery disease and transient ischemic attacks, mediated through inhibition of prostaglandin synthesis and platelet aggregation.
Answers are grounded in this paper and cite their sources.
Supports aspirin use in CAD and TIA; leaves open comparative dosing trials across indications.
1 The ubiquitous actions of the cyclo-oxygenase inhibitors are described. 2 These include the inhibitory effect on prostaglandin synthesis and the direct effect of aspirin on lymphocytes and their ability to produce lymphokines. 3 Aspirin reduces some types of platelet aggregation possibly involving inhibition of the precursors of thromboxane A2 and prostacyclin. 4 The therapeutic implications in relation to transient ischaemic attacks, coronary artery disease and reno-allograft rejection are discussed. 5 The beneficial and adverse effects on the gastro-intestinal tract are described. 6 The effects of aspirin-like drugs on the genito-urinary tract are described with particular reference to their adverse effects on labour and their therapeutic effect on dysmenorrhoea.
No takes yet. Share an insight, caveat, or question.
Ae et al. (1980) conducted a review in Various conditions including transient ischaemic attacks, coronary artery disease, and dysmenorrhoea. Aspirin and other cyclo-oxygenase inhibitors was evaluated. Aspirin and other cyclo-oxygenase inhibitors have diverse therapeutic applications, including potential benefits in transient ischaemic attacks, coronary artery disease, and dysmenorrhoea.
Synapse has enriched 10 related papers. Consider them for comparative context: